The neuronal ubiquitin/proteasomal pathway has been implicated in the pathogenesis of Alzheimer's disease (AD). We now show that a component of the pathway, ubiquitin C-terminal hydrolase L1 (Uch-L1), is required for normal synaptic and cognitive function. Transduction of Uch-L1 protein fused to the transduction domain of HIV-transactivator protein (TAT) restores normal enzymatic activity and synaptic function both in hippocampal slices treated with oligomeric Ab and in the APP/PS1 mouse model of AD. Moreover, intraperitoneal injections with the fusion protein improve the retention of contextual learning in APP/PS1 mice over time. The beneficial effect of the Uch-L1 fusion protein is associated with restoration of normal levels of the PKA-regulatory subunit IIa, PKA activity, and CREB phosphorylation.
INTRODUCTION
Cognitive deficits following Ab elevation are seen in amyloid-depositing models such as double transgenic (Tg) mice overexpressing APP (K670N:M671L) together with PS1 (M146L) (APP/PS1 mice). These mice overproduce Ab and show inhibition of long-term potentiation (LTP), a type of synaptic plasticity related to memory, at young ages . Since application of Ab to hippocampal slices from wild-type (wt) animals inhibits LTP, the deficit in Tg animals is likely to be due to Ab rather than other changes in the brain (Cullen et al., 1997; Itoh et al., 1999; Walsh et al., 2002) . LTP inhibition in slices is reversible by treatments that raise the intracellular concentration of cyclic AMP (cAMP) (Vitolo et al., 2002) . It has been proposed that the effect of Ab on LTP and memory is mediated by the inhibition of phosphorylation of the cAMP response element binding protein (CREB) (Dineley et al., 2001 (Dineley et al., , 2002 Gong et al., 2004; Vitolo et al., 2002 ), a transcription factor that is activated by cAMP-dependent protein kinase (PKA). PKA activity is regulated both by the dissociation of its catalytic and regulatory subunits and by the degradation of its regulatory subunits by the ubiquitin-proteasome system (UPS) (Chain et al., 1999) . Moreover, long-term facilitation, a form of plasticity occurring in Aplysia, is mediated by a concurrent increase of cAMP and of a neuron-specific ubiquitin C-terminal hydrolase (Uch), an enzyme that enhances the recycling of ubiquitin (Hegde et al., 1997) .
The brains of AD patients show an accumulation of ubiquinated proteins (de Vrij et al., 2004) , suggesting inhibition of the protein degradation machinery. Analysis of proteasome function in postmortem human AD brains shows little change in the levels of mRNA or protein for the major proteasomal components but a strong inhibition of degradative activity (Keller et al., 2000) . Interestingly, Uch-L1, a neuron-and testis-specific enzyme, is downregulated in AD brains. AD brains show prominent Uch-L1 immunostaining associated with neurofibrillary tangles and levels of soluble Uch-L1 inversely proportional to the number of tangles (Choi et al., 2004) .
We investigated the effects of Uch-L1 inhibition on LTP and memory and asked if increasing Uch activity by the application of a fusion protein containing Uch-L1 rescues synaptic dysfunction in hippocampal slices treated with oligomeric Ab. These studies were validated on the APP/ PS1 model of AD. We also examined whether Uch activity and levels of Uch-L1 are modified in the double Tg mice. Finally we examined the effects of exogenous Uch-L1 on the PKA-CREB pathway.
RESULTS

Uch-L1 Activity Is Required for Normal Synaptic Function
To test if Uch-L1 is required for synaptic function in the mouse brain we measured hydrolase activity and LTP in hippocampal slices exposed to the Uch-L1 inhibitor, LDN-57444 (LDN), a reversible, competitive, active sitedirected isatin oxime with an IC 50 value of 0.88 mM for Uch-L1 and 25 mM for its systemic isoform, Uch-L3 (Liu et al., 2002) . Maximal inhibition of Uch activity (70%) was obtained with 5 mM LDN in 1 hr (Figures 1A and 1B) . This was not due to inhibition of Uch-L3 since there was no reduction in hydrolysis of Nedd8-AMC, a ubiquitin-like protein that binds to and is cleaved by Uch-L3, when 20 nM Uch-L3 was incubated with 5 mM LDN (Wada et al., 1998) (Figure S1A ). We found a 15 min perfusion (A) Reduction of Uch activity by exposure to the Uch-L1 inhibitor LDN-57444 (LDN) for 2 hr (n = 10/group, p < 0.05 at 0.9 mM and p < 0.01 at concentrations above 2.7 mM). (B) Time course of the reduction of Uch activity by exposure of hippocampal slices to 5 mM LDN (n = 5/group, p < 0.05 at 15 min and p < 0.01 after 30 min). (C) BST at the Schaffer collateral/CA1 connection of hippocampal slices was not affected by 2 hr exposure to 5 mM LDN (n = 6 slices from 6 mice per condition; two-way ANOVA F(1,10) = 1.04, p > 0.05). (D) CA1-LTP was reduced by exposure to LDN (5 mM) for 2 hr (n = 6 slices from 6 mice per condition; two-way ANOVA [F(1,10) = 25.04, p < 0.001] and planned comparison showed that the groups were significantly different at each time point after tetanus [p < 0.001]). The inhibitor did not affect baseline transmission in nontetanized slices (n = 3 slices from 2 mice; data not shown). The arrows indicate time and pattern of the tetani in this and the following figures. (E) CA1-BST was strongly reduced by 4 hr exposure to 5 mM LDN (n = 6 slices from 6 mice for each condition; two-way ANOVA F(1,10) = 8.14, p < 0.05). (F) LTP is strongly reduced by 4 hr exposure to 5 mM LDN (n = 6 slices from 6 mice for each condition; two-way ANOVA [F(1,10) = 45.76, p < 0.001] and planned comparison showed that the groups were significantly different at each time point after tetanus [p < 0.001]). The inhibitor did not affect baseline transmission in nontetanized slices (n = 4 slices from 2 mice; data not shown). All data shown are mean ± SEM. with 5 mM LDN reduced enzymatic activity by 20% but did not affect basal synaptic transmission (BST) or LTP at the CA3-CA1 connection (Figures S1B and S1C). A 2 hr exposure reduced activity by 70% and diminished LTP without affecting BST, and a 4 hr exposure reduced both BST and LTP ( Figures 1C-1F) . A similar reduction in LTP with normal BST was observed following 2-4 hr of perfusion with 2.7 mM LDN ( Figure S1D ) that reduced enzymatic activity by 40% but not with a concentration of 1 mM that produced only a 20% reduction ( Figure 1A ). These findings are consistent with recent work showing normal LTP, contextual learning, and cued learning in Uch-L3 null mice (Wood et al., 2005) . The LDN-induced alterations are similar to those induced by Ab treatment and those seen in APP/PS1 mice (see below) where we have found Uch-L1 activity to be decreased by approximately 30% (Figure 2A ).
Restoration of Uch-L1 Levels Corrects Deficits in Synaptic Transmission in Ab-Treated Hippocampal Slices and in Slices from APP/PS1 Mice To manipulate the levels of Uch-L1, we produced a fusion protein in which the 11-amino acid transduction domain of the HIV-transactivator protein (TAT) was fused with an HA tag and Uch-L1 (TAT-HA-Uch-L1 = V-Uch-L1) (Wadia and Dowdy, 2003; Wadia et al., 2004) . As controls we produced fusion proteins between TAT and HA (TAT-HA = V) and between TAT and inactive Uch-L1 from which 57 amino acids (130 to 186) are deleted (V-iUch-L1) (see below).
Hippocampal slices perfused with V-Uch-L1, V-iUch-L1, or V (20 nM) for 1 hr followed by fixation and staining with anti-Uch-L1 or anti-HA, as appropriate, showed a 3-fold increase in staining intensity as compared to vehicle-treated slices from the same animals ( Figure S2A ). These proteins also enter the brains of living animals -L1 (20 nM) re-established normal Uch activity in slices exposed to 200 nM Ab for 20 min (n = 9 in all groups, p < 0.01 in the Ab group compared to the vehicle group).
(B) Western blotting shows that 1 hr preincubation with V-Uch-L1 (20 nM) blocks the decrease of monoubiquitin levels in hippocampal slices treated with 200 nM Ab for 20 min. Band intensities were measured and normalized for ERK1/2 intensities (n = 8 in all groups, p < 0.01 in Ab group compared to the vehicle group). All data shown are mean ± SEM. following i.p. injection and cultured neurons (Supplemental Results and Figures S2B and S2C) . Finally, V-Uch-L1 is found exclusively in the soluble fraction of hippocampal homogenates 1 hr after its administration ( Figure S2D) .
Uch enzymes play a major role in the generation of monomeric ubiquitin (Wilkinson, 2000) . Treatment with oligomeric Ab42 (200 nM for 20 min) decreases monoubiquitin levels by 70% ( Figure 2B ). When slices are incubated for 1 hr with V-Uch-L1 (20 nM) before Ab treatment (20 min in the continued presence of V-Uch-L1) normal monoubiquitin levels and Uch activity are maintained (Figures 2A and  2B ). V-Uch-L1 alone produced a slight increase in monoubiquitin levels and in enzymatic activity while inactive V-iUch-L1 and V had no effect. These results show that the V-Uch-L1 fusion protein enters cells, is enzymatically active, and is capable of re-establishing normal hydrolase levels.
Perfusion of hippocampal slices with oligomeric Ab (200 nM) reduces LTP by 60% in CA1 compared to vehicletreated controls (Figures 3A and 3B) (Cullen et al., 1997; Itoh et al., 1999; Vitolo et al., 2002; Walsh et al., 2002) . Pretreatment with V-Uch-L1 (20 nM) for 1 hr followed by perfusion with 200 nM oligomeric Ab plus V-Uch-L1 before theta-burst stimulation protected against LTP suppression ( Figure 3A ). V-iUch-L1 was not protective ( Figure 3B ). V-Uch-L1 alone had no effect on LTP evoked with 3 thetaburst trains, but it enhanced LTP when applied before a weaker tetanus (1 theta-burst train) ( Figure S3 ), suggesting that the stronger tetanus produces maximal potentiation that cannot be further augmented by exogenous Uch-L1 (a similar finding was observed with the PDE4 inhibitor rolipram that increased LTP following weak tetanus [Barad et al., 1998 ] but failed to further enhance LTP with a strong tetanus [Vitolo et al., 2002] ).
These results show clear parallels between the effect of V-Uch-L1 on hydrolase activity and its ability to block deleterious actions of Ab. However, Uch-L1 has two distinct enzymatic activities. The C90 and H161 sites are involved in both hydrolase and ligase function whereas the S18 site modulates dimer formation that correlates with the ligase activity (Liu et al., 2002) . To investigate which function of Uch-L1 is involved in its effect on Ab-induced block of LTP, we used site-directed mutagenesis to produce three mutant constructs of V-Uch-L1: V-Uch-L1(C90S), V-Uch-L1(S18Y), and V-iUch-L1. The last of these has a 57 amino acid deletion (130-186) including the H161 site. V-Uch-L1 and V-Uch-L1(S18Y) have similar hydrolase activity, while V-Uch-L1(C90S), V, and V-iUch-L1 have little or no activity ( Figure 3C ). Preincubation (1 hr) with either V-Uch-L1(C90S) or V-iUch-L1 failed to protect against LTP suppression while V-Uch-L1(S18Y) protected to the same extent as an unmodified construct ( Figures 3D and 3E ). V-Uch-L1(C90S) alone produced a significant decrease (60%) in potentiation compared to slices treated with vehicle or V-iUch-L1 ( Figures 3D and 3E ), suggesting that it is a dominant-negative inhibitor.
Since the S18Y form dimerizes at higher concentrations than wt Uch-L1 (Liu et al., 2002) , we examined the effect of different concentrations of V-Uch-L1 and V-Uch-L1(S18Y) on LTP rescue after Ab, reasoning that the lower ligase activity of the S18Y form at a given concentration should produce less potentiation if ligase activity is critical for rescue. We found no difference in the two ( Figure 3F ). We also examined dimer formation by V-Uch-L1 at concentrations of 1 mM and 5 mM-many times higher than those used in these experiments-and found no dimer formation at 1 mM ( Figure S4) .
Similar results were obtained in slices from APP/PS1 mice. These mice start depositing Ab at 8-10 weeks and partially reproduce the cognitive deficits that occur in AD patients. They display impaired LTP and contextual learning at 3-4 months of age and deficits in BST at 5-6 months of age . They also show a reduction of basal CREB levels (Gong et al., 2004) and an increase in PKA-RIIa subunit ( Figure S5 ). Examination of Uch-L1 in these animals revealed little difference between APP/ PS1 and wt mice in mRNA levels for Uch-L1 ( Figure 4A ) or Uch-L3 ( Figure S6A ). There was no change in total Uch-L1 protein level in their hippocampi. However, there was a 30% decrease of Uch-L1 protein in the soluble fraction of hippocampal homogenates from APP/PS1 mice compared to wt littermates with a similar increase in the insoluble fraction ( Figures 4B and 4C ). This reduction is reflected in the soluble Uch activity. The specific activity of the Uch-L1 in the insoluble fraction was very low (15% of the soluble enzyme). Thus, the total activity in the APP/ PS1 mice was decreased ( Figure 4D ). APP/PS1 mice showed a 30% decrease in total hippocampal hydrolase activity at 4-6 months and a 45% loss at 15-18 months. Single Tg APP mice showed only a slight decrease of activity at 4-6 months but a 30% loss at 15-18 months. wt and single Tg PS1 mice did not differ significantly and showed a reduction of about 10% in activity at 15-18 months (Figure 4E) . When mice were injected with V-Uch-L1 (0.02-0.04 g/kg, i.p.), Uch activity returned to control levels in APP/PS1 mice and increased above control level in wt mice ( Figure 4F ). Since the Ub-AMC assay is not specific for Uch-L1, we also measured Uch-L3 protein in soluble and insoluble fractions of hippocampal tissue from APP/ PS1 and wt littermates and used the Nedd8-AMC assay to examine total Uch-L3 activity ( Figure S6 ). We found no difference in either among genotypes, suggesting that Uch-L3 is not involved in the decrease of hydrolase activity. Taken together these findings support the hypothesis that a reduction in Uch-L1 protein levels leads to a lower hydrolase activity and the impairment of both synaptic function and cognition in the APP/PS1 mice. The loss of hydrolase activity in the APP/PS1 mice is less than the reduction in slices treated with 5 mM LDN for 60 min (30% versus 70%), suggesting that Uch-L1 activity is not completely blocked in APP/PS1 mice. Indeed, if hippocampal slices of wt and APP/PS1 mice were exposed for 2 hr to 5 mM LDN, the inhibitor reduces enzymatic activity to the same level in the two genotypes (70% of values in vehicle-treated wt slices) ( Figure S7A ). However, LDN (5 mM for 2 hr) does not reduce potentiation further in APP/PS1 slices or in wt slices exposed to 200 nM Ab (Figures S7B and S7C), suggesting that a 30% decrease of hydrolase activity is sufficient to produce maximal levels of LTP reduction.
When hippocampal slices from 4-month-old APP/PS1 mice are perfused with V-Uch-L1 (20 nM) for 1 hr, Uch activity is restored and LTP amplitude following theta burst is elevated above vehicle-treated slices and is similar to that of wt mice (Figures 5A and 5B) . Neither V-nor ViUch-L1-treated slices differed from vehicle-treated slices. V-Uch-L1 had no effect on LTP amplitude in hippocampal The fusion protein did not affect LTP in slices that were not treated with Ab and did not affect basal transmission in nontetanized slices (data not shown). Ab alone markedly reduced potentiation (Ab, n = 14 slices from 14 mice; V-Uch-L1 plus Ab, n = 15 slices from 15 mice; V-Uch-L1, n = 9 slices from 9 mice; V-Uch-L1 with no tetanus, n = 5 from 3 mice; a two-way ANOVA revealed a significant difference between the V-Uch-L1 plus Ab group compared to the Ab alone group [F(1, 29) = 42.75, p < 0.001], and planned comparisons showed that the groups were significantly different at each time point after tetanus (p < 0.001).
(B) Pretreatment with V-iUch-L1 (20 nM) for 1 hr followed by V-iUch-L1 (20 nM) plus Ab (200 nM) for 20 min did not reverse the Ab-induced impairment of CA1-LTP, or affect LTP in slices that were not treated with Ab, or affect basal transmission in nontetanized slices (data not shown). These experiments were interleaved with those described in (A) (vehicle, n = 13 slices from 12 mice; V-iUch-L1, n = 8 slices from 8 mice; V-iUch-L1 plus Ab, n = 9 slices from 9 mice; V-iUch-L1 with no tetanus, n = 5 slices from 4 mice; a two-way ANOVA showed similar values with V-iUch-L1 plus Ab and with Ab alone [F(1, 21) = 1.58, p > 0.05]). Similar results were obtained with V (20 nM) with or without Ab (data not shown). (C) Uch activity of mutant V-Uch-L1 constructs. V-Uch-L1(S18Y) is similar in activity to V-Uch-L1 (p > 0.05), while V-Uch-L1 (C90S), V, and V-iUch-L1 are inactive (p < 0.001) (n = 3/group). (D) Pretreatment with V-Uch-L1(C90S) (20 nM) for 1 hr followed by V-Uch-L1(C90S) (20 nM) plus Ab (200 nM) for 20 min failed to reverse the Ab-induced impairment of CA1-LTP (n = 15 slices from 14 mice). The fusion protein severely impaired potentiation in slices even in the absence of Ab (n = 13 slices from 10 mice) compared to slices that were treated with vehicle alone (n = 12 slices from 8 mice [F(1, 23) = 23.41, p < 0.001], and planned comparisons showed that the groups were significantly different at each time point after the tetanus [p < 0.001]), whereas it did not affect basal transmission in nontetanized slices (n = 5 from 3 mice; data not shown). These experiments were interleaved with those described in (E). A two-way ANOVA did not reveal a significant difference between the V-Uch-L1(C90S) plus Ab group compared to the V-iUch-L1 plus Ab group (n = 9 slices from 9 mice [F(1, 22) = 1.44, p > 0.05]). (E) Pretreatment with V-Uch-L1(S18Y) (20 nM) for 1 hr followed by V-Uch-L1(S18Y) (20 nM) plus Ab (200 nM) for 20 min completely reversed the Abinduced impairment of CA1-LTP (n = 14 slices from 13 mice). A two-way ANOVA revealed a significant difference between the V-Uch-L1(S18Y) plus Ab group and the V-iUch-L1 plus Ab group (F(1, 21) = 42.08, p < 0.001, and planned comparisons showed that the groups were significantly different at each time point after the tetanus [p < 0.001]). The fusion protein affected neither the amounts of potentiation in slices that were not treated with Ab (n = 15 slices from 9 mice) nor basal transmission in nontetanized slices (n = 6 slices from 4 mice; data not shown). (F) Pretreatment with different concentrations of V-Uch-L1(S18Y) and V-Uch-L1 for 1 hr followed by cotreatment with TAT-fusion proteins and Ab (200 nM) and for 20 min produced similar amounts of rescue of LTP (n = 12 for each group). Nonlinear regression analysis was used to fit curves for different concentrations using GraphPad Prism software (GraphPad Software Inc., San Diego, CA). A two-way ANOVA did not reveal a significant difference between the two groups (F(6, 168) = 0.3, p > 0.05). All data shown are mean ± SEM. slices from wt mice ( Figure 5B ). There was no difference in BST among the different groups as measured by plotting the fEPSP slope versus the stimulus intensity or versus the amplitude of the fiber afferent volley (data not shown). Similar effects were seen in older APP/PS1 mice (12-18 months) with severe plaque load ( Figures 5C and 5D ). BST in APP/PS1 mice, initially lower than in wt mice, was also improved in the V-Uch-L1 group as compared to vehicle-or V-iUch-L1-treated slices ( Figure 5E ).
Exogenous Uch-L1 Improves Contextual Fear Learning in APP/PS1 Mice Fear conditioning, a form of learning impaired in several AD mouse models (Dineley et al., 2002; Gong et al., 2004) , was used to determine whether Uch-L1 is critical in this form of memory in mice. The fear-conditioning paradigm depends on the hippocampus and amygdala. The hippocampus is required for contextual fear learning (Phillips and LeDoux, 1992) , a form of associative memory in which mice must associate a neutral stimulus with an aversive one. We used the inhibitor LDN to probe the role of Uch-L1 in this process. Following a single i.p. injection of inhibitor (0.4 mg/kg), maximal inhibition of hydrolase activity (40% of control) was seen at 30 min post-injection with recovery by 8 hr ( Figure 6A ). For fear conditioning, LDN-treated and vehicle-treated mice were placed in a novel context (fear-conditioning box) and were exposed to a tone (conditioned stimulus [CS]) paired with a mild Figure 4 . Uch-L1 Activity Is Downregulated in APP/PS1 Mice (A) Quantitative RT-PCR analysis showed no difference in the expression levels of Uch-L1 mRNA purified from the hippocampi of 4-to 6-month-old APP/PS1 mice and their wt littermates. Data were normalized against GAPDH (n = 9 for both genotypes, p > 0.05). (B) Quantitative Western blot analysis showed a reduction of the soluble fraction of Uch-L1 protein levels in hippocampi from 4-to 6-month-old APP/ PS1 mice compared to wt littermates (n = 3 for both genotypes, p < 0.01, data normalized against ERK1/2). (C) Quantitative Western blot analysis showed an increase of the insoluble fraction of Uch-L1 protein levels in hippocampi from 4-to 6-month-old APP/PS1 mice compared to wt littermates (n = 3 for both genotypes, p < 0.01, data normalized against ERK1/2). (D) Hippocampal Uch activity was measured in soluble, insoluble, and total extracts of 4-to 6-month-old APP/PS1 mice and wt littermates (n = 3 for all the groups). Both soluble and total extracts showed a decrease in activity in APP/PS1 mice compared to wt mice (p < 0.01), while the insoluble fraction showed no change in activity between genotypes (p > 0.05). The activity of Uch-L1 in the insoluble fraction was markedly lower than that in the soluble fraction in the wt mice (p < 0.001). Activity was normalized with respect to the activity of wt soluble protein.
(E) Total hippocampal Uch activity was decreased in APP/PS1 mice of different ages compared to wt littermates (n = 3 for both wt and APP/PS1 mice, p < 0.01). Single transgenic APP mice showed a significant decrease of Uch activity at 15-18 months of age (p < 0.01). A slight reduction in Uch activity is also present in wt and single Tg PS1 mice at 15-18 months of age. (F) V-Uch-L1 re-established normal total Uch activity in APP/PS1 mice; V-Uch-L1 increased total Uch activity in wt mice (n = 3 for each group, p < 0.01 for both genotypes when comparing vehicle-treated animals with V-Uch-L1-treated mice). All data shown are mean ± SEM.
foot shock (unconditioned stimulus [US]) (training phase of the fear conditioning) (Bourtchuladze et al., 1994) . Conditioning was assessed 24 hr later by measuring ''freezing'' behavior-the absence of all movement except respiration-in response to the context (contextual conditioning) or the auditory cue (CS) within a completely different context (cued conditioning). During the training phase, no difference in the freezing of LDN-or vehicle-injected mice was seen. Twenty-four hours later there was a decrease in the freezing time of LDN-treated mice to 65% of that of vehicle-treated mice in contextual conditioning ( Figure 6B ). On the other hand, cued fear conditioning showed no difference in freezing behavior between the two groups (data not shown), suggesting that the amygdala, which is involved mainly in cued conditioning (Phillips and LeDoux, 1992) , is not impaired by Uch-L1 inhibition. The difference in the freezing time persisted when contextual learning was assessed 7, 14, and 21 days after exposure to the electric shock, with LDN-injected mice having values of 70% of those in vehicle-treated mice at 21 days ( Figure 6B ). LDN failed to impair contextual learning when it was injected at 4 and 1 hr before the shock or at 1 hr after Figure 5 . Uch-L1 Effects on Synaptic Function in APP/PS1 Mice (A) Incubation for 1 hr with V-Uch-L1 (20 nM) completely reversed the impairment of CA1-LTP in slices from 4-month-old APP/PS1 mice (n = 15 slices from 12 males), whereas V-iUch-L1 (20 nM) had no effect (n = 10 slices from 9 males). Two-way ANOVA revealed a significant difference between the groups (F(1, 23) = 73.81, p < 0.001), and planned comparisons showed that the groups were significantly different at each time point after the tetanus (p < 0.001). Neither V-Uch-L1 nor V-iUch-L1 affected baseline transmission in slices that did not receive tetanus (n = 7 slices from 5 males for each group; data not shown). V (20 nM) produced results similar to V-iUch-L1 in this and the following experiments (data not shown). (B) Incubation for 1 hr with V-Uch-L1 (20 nM) or V-iUch-L1 (20 nM) had no effect on LTP (n = 15 slices from 10 males and 10 slices from 10 males, respectively; F(1,23) = 2.04, p > 0.05) or baseline transmission (n = 4 slices from 3 males and 5 slices from 4 males, respectively; data not shown) in slices from 4-month-old wt mice. (C) Incubation for 1 hr with V-Uch-L1 (20 nM) reversed the impairment of LTP in slices from 12-to 18-month-old APP/PS1 mice (n = 14 slices from 11 males). V-iUch-L1 (20 nM) had no effect (n = 9 slices from 6 males). Two-way ANOVA revealed a significant difference between the two APP/PS1 groups (F(1, 21) = 16.21, p < 0.001), and planned comparisons showed that the groups were significantly different at each time point after the tetanus (p < 0.001). Neither V-Uch-L1 nor V-iUch-L1 affected baseline transmission in nontetanized slices (n = 6 slices from 5 males for both treatments; data not shown). (D) Incubation for 1 hr with V-Uch-L1 (20 nM) or V-iUch-L1 (20 nM) did not affect LTP (n = 13 slices from 11 males and 13 slices from 11 males, respectively; F(1,24) = 1.38, p > 0.05) or baseline transmission in slices from 12-to 18-month-old wt mice (n = 7 slices from 4 males and 7 slices from 5 males, respectively; data not shown). (E) Incubation for 1 hr with V-Uch-L1 (20 nM) improved BST at the CA3-CA1 connection of slices from 12-to 18-month-old APP/PS1 mice whereas V-iUch-L1 (20 nM) did not (F(1, 21) = 18.05, p < 0.001; planned comparisons showed that the groups were significantly different between 7 and 35 V, p < 0.01) No statistically significant difference was found in the fEPSP slope values of V-Uch-L1-treated APP/PS1 mice compared with those of V-iUch-L1-treated and V-Uch-L1-treated wt mice (F(1, 25) = 1.68 and F(1, 25) = 2.74, respectively, p > 0.05 for both). V-iUch-L1-treated slices had similar BST as TAT-free vehicle-treated slices in both APP/PS1 mice and wt littermates (p > 0.05). All data shown are mean ± SEM. the shock (Supplemental Experimental Procedures), suggesting that there is a time window at 4 hr after the electric shock during which Uch-L1 is required for contextual fear memory processes in hippocampus. Similar to LDN, V-Uch-L1(C90S) (0.04 g/kg i.p., injected 4 hr after the electric shock) impaired contextual learning assessed at 1 day and at 7, 14, and 21 days compared to vehicle-treated mice ( Figure 6C ), suggesting that it is a dominant-negative inhibitor as described above for the experiments on LTP ( Figure 3D) .
When 3-to 5-month-old APP/PS1 mice were injected with V-Uch-L1 or V-iUch-L1 or V (0.02-0.04 g/kg, i.p.) 4 hr before training, no significant differences in freezing behavior were seen between the groups in the training phase. Treatment with V-Uch-L1 in APP/PS1 mice failed to re-establish normal freezing when the animals were reintroduced into the same context 1 day after training (Figure 6D ). There were also no differences between the four groups in cued conditioning (data not shown). However, treatment with V-Uch-L1 greatly increased the freezing time in APP/PS1 mice compared to V-iUch-L1-and V-treated APP/PS1 littermates when contextual learning was assessed over time. V-Uch-L1-treated APP/PS1 mice showed about 85% of the freezing time of wt mice, compared to 40% for V-iUch-L1-treated APP/PS1 mice at 21 days after training. V-Uch-L1 did not change the freezing time in wt littermates compared with control wt mice (95% that of V-iUch-L1-treated wt mice) ( Figure 6D ).
Given the physiological and behavioral effects of VUch-L1 treatment in APP/PS1 mice, we examined whether (C) A single injection of V-Uch-L1(C90S) (0.02-0.04 g/kg, i.p) 4 hr prior to training of fear conditioning worsened contextual conditioning performance in mice exposed to the context at 1, 7, 14, and 21 days after training (n = 13, 9 males and 4 females in V-Uch-L1(C90S)-injected mice versus n = 15, 10 males and 5 females in vehicle-treated mice; two-way ANOVA F(1, 26) = 4.69 [p < 0.05] and planned comparisons showed a statistically significant difference at each time point between V-Uch-L1(C90S)-and vehicle-injected mice, [p < 0.05]). (D) A single injection of V-Uch-L1 but not V-iUch-L1 (0.02-0.04 g/kg, i.p) 4 hr prior to training of fear conditioning re-established normal freezing time during retention of contextual learning at 7, 14, and 21 days after training in APP/PS1 mice (V-Uch-L1, n = 22, 10 males plus 12 females; V-iUch-L1, n = 12, 5 males plus 7 females). V-Uch-L1 had no effect on the freezing responses of wt mice (V-Uch-L1, n = 18, 9 males plus 9 females; V-iUch-L1, n = 14, 7 males plus 7 females). Two-way ANOVA followed by the Bonferroni test revealed a statistically significant difference among the four groups (F(3, 64) = 19.53 [p < 0.001]). V produced similar results as V-iUch-L1 (data not shown). All data shown are mean ± SEM. treatment with V-Uch-L1 affected Ab levels, a hallmark of AD. ELISA of extracts of hippocampal and cerebral cortices revealed no difference in Ab42 levels 4 hr after injection of V-Uch-L1 (0.02-0.04 g/kg, i.p.) in 4-month-old APP/PS1 mice (hippocampal Ab42, about 94% that of vehicle-treated APP/PS1 mice; cortical Ab42, about 104%; Figure S8A ). No Ab was detected in wt littermates. Similar results were obtained by measuring Ab levels in mice that received V-Uch-L1 and were tested for fear conditioning over 21 days (hippocampal Ab42, about 106% that of vehicle-treated APP/PS1 mice; cortical Ab42, about 103%; Figure S8B ). Thus, it is unlikely that a single injection of V-Uch-L1 produces its beneficial effects on learning and memory in the APP/PS1 mice by interfering with Ab production or clearance (Supplemental Discussion).
Taken together, these data strongly suggest that Uch-L1 activity plays a role in normal contextual fear learning, that exogenous Uch-L1 improves the retention of contextual learning in APP/PS1 mice, and that the changes are not dependent on changes in Ab levels.
The Effects of Exogenous Uch-L1 Are Mediated by the PKA-CREB Pathway
Proteolysis of the PKA-regulatory (PKA-R) subunit coincides with Uch induction and CREB-dependent longterm facilitation in Aplysia (Chain et al., 1999; Hegde et al., 1997) . We tested whether the effect of V-Uch-L1 on Ab-induced synaptic dysfunction is associated with reversal of the Ab-induced block of PKA-R degradation (Vitolo et al., 2002) . Treatment of hippocampal slices with 200 nM Ab for 20 min reduced PKA activity by 30% ( Figure 7A ). Pretreatment with 20 nM V-Uch-L1 for 1 hr before applying Ab blocked the reduction, while neither V-iUch-L1 (20 nM) nor V had any effect. Measurement of the PKA-RIIa subunit levels in hippocampal slices as a function of exposure to Ab42 (200 nM for 20 min) showed a marked increase in RIIa that was blocked by pretreatment with 20 nM V-Uch-L1 for 1 hr before addition of 200 nM Ab ( Figure 7B ). Both V-iUch-L1 or V were without effect. Treatment with Ab blocks the increase in phosphorylated CREB induced by theta burst in hippocampal slices as seen with an antibody specific to phosphoserine 133. The inhibition is reversed by V-Uch-L1 pretreatment ( Figure 7C ), but not by vehicle, V, or V-iUCH-L1. Consistent with these findings, suggesting that the PKA-CREB pathway mediates the effects of Uch-L1 on Ab-induced synaptic dysfunction (Figure 7D ), the Ab-induced reduction in both PKA activity and glutamate-induced increase of CREB phosphorylation were re-established in hippocampal cell cultures treated with V-Uch-L1 plus Ab (Supplemental Results and Figure S9 ).
DISCUSSION
It has been suggested that UPS dysfunction plays a major role in the pathogenesis of several neurodegenerative diseases (Ciechanover and Brundin, 2003) . Ubiquitin is seen in neurofibrillary tangles and senile plaque neurites of AD brains, and both PS1 and PS2 are targets for the ubiquitin system (Kim et al., 1997) . Proteasome activity is inhibited by Ab and exposure to oxidative stress (Almeida et al., 2006; Gregori et al., 1995; Grune et al., 1995) , both of which are believed to contribute to the progression of AD (Markesbery, 1997; Mattson, 1997) . A possible link between Uch enzymes, memory, and AD is suggested by the requirement for Uch in long-term facilitation in Aplysia (Chain et al., 1999) , by reports of decreased levels of Uch-L1 in postmortem AD brain (Choi et al., 2004) , and by Ab aggregates and intraneuronal ubiquitin deposits in gracile axonal dystrophy (gad) mice that lack Uch-L1 activity (Ichihara et al., 1995; Saigoh et al., 1999) . Our studies show a reduction of soluble Uch-L1 protein levels in the hippocampus of APP/PS1 mice. Inhibition of Uch-L1 activity by the specific Uch-L1 inhibitor LDN leads to the inhibition of hippocampal LTP. Transduction of Uch-L1 protein restores Ab-induced inhibition of LTP and also re-establishes normal Uch activity, basal neurotransmission, and synaptic plasticity and improves associative memory in APP/PS1 mice.
Since Uch-L1 has both hydrolase and ligase activity (Liu et al., 2002) , we investigated which function of Uch-L1 is involved in its effects on Ab-induced synaptic dysfunction. Deletion of the H161 site in the V-Uch-L1 protein or its mutation in C90S completely eliminates effects on LTP, while mutation of the S18Y site has no effect. Given that ligase activity correlates with dimerization of Uch-L1, we have examined the formation of dimers and other aggregates in the V-Uch-L1 preparation. As previously reported (Liu et al., 2002) , dimers were seen at 5 mM but not at 1 mM ( Figure S4 ). In addition, since the S18Y form dimerizes only at higher concentrations than the wt form, we attempted to rescue LTP using different concentrations of V-Uch-L1 and V-Uch-L1(S18Y). The less efficient ligase activity of the S18Y form (Liu et al., 2002) should produce lower amounts of potentiation if ligase activity is relevant to the rescue effect. Despite extending the concentration as low as 5 nM, there was no difference between the two forms ( Figure 3F ). Since these concentrations are 1/250 th -1/ 1000 th of the dimer-forming concentration in vitro, it is unlikely that the rescue of LTP is due to ligase activity. However, we still cannot rigorously exclude the possibility that a local event (i.e., membrane binding at synaptic vesicles) might allow for such activity. Nevertheless, the main observations of this manuscript showing that exogenous Uch-L1 ameliorates Ab-induced synaptic and memory dysfunction are clear and have important implications for the treatment of diseases characterized by abnormal Ab elevation.
V-Uch-L1 improves the retention of contextual fear conditioning over a 3 week period but, unlike rolipram, a PDE4 inhibitor, does not improve learning the day after training (Gong et al., 2004) . One explanation is that Uch-L1 might stabilize synaptic circuitry via alterations in gene expression that take longer than one day to fully develop. Consistent with this hypothesis, rolipram has a beneficial effect on synaptic and cognitive function of APP/PS1 mice that persists for several months (B) Quantitative Western blot analysis of protein extracts from hippocampal slices showed an increase in PKA-RIIa levels after treatment with 200 nM Ab for 20 min (n = 8, p < 0.01). Preincubation with V-Uch-L1 (20 nM) for 1 hr re-established normal levels of RIIa despite the presence of Ab (n = 7, p < 0.01, compared to Ab alone) (vehicle and V-Uch-L1 alone, n = 8). All samples are normalized against unphosphorylated ERK. (C) Upper panel: representative examples of hippocampal slices stained with a phospho-CREB antibody. The slices were fixed 60 min after vehicle, Ab, V-Uch-L1 plus Ab, and V-Uch-L1 with and without tetanus. Left, lower-power (43) view of the entire slice. Right, higher-power (163) view of CA1 cell pyramidal area. Lower panel: plot of fluorescence intensities showing Ab blockade of the increase in CA1-phospho-CREB after tetanus (n = 7 both for vehicle-and Abalone-treated-slices, p < 0.01), whereas V-Uch-L1 (20 nM for 1 hr) followed by 200 nM Ab plus V-Uch-L1 (20 nM) for 20 min re-established the tetanusinduced increase in phospho-CREB (n = 7, p < 0.01 compared to tetanized slices treated with Ab alone). V-Uch-L1 alone had no effect (n = 7). In the absence of theta burst neither Ab42 alone nor V-Uch-L1 alone nor V-Uch-L1 paired with Ab42 induced changes (n = 5 for each group). (D) Schematic representation of Ab modulation of the ubiquitin-proteasome-PKA-CREB pathway: a working hypothesis showing that exogenous Uch-L1 re-establishes normal memory. After binding with a putative membrane receptor, Ab inhibits adenylate cyclase (AC) (Vitolo et al., 2002) and proteasomal degradation of the RIIa subunit (R), resulting in its accumulation and a shift of the equilibrium in the PKA complex toward the inactive tetramer. As a consequence, the transcription factor CREB cannot be phosphorylated and initiate transcription. Transduction of Uch-L1 re-establishes normal proteasomal activity leading to normal levels of RIIa subunit. The freed catalytic subunit is activated and can phosphorylate CREB at Ser133. All data shown are mean ± SEM. after a brief course of treatment. These persistent effects are reflected in stabilization of phospho-CREB levels (Gong et al., 2004) and restoration of dendritic spine density to control levels (D. Moolman, personal communication) in the APP/PS1 animals. Indeed, the formation of new synaptic connections probably underlies long-term memory formation in several species with a mechanism that is dependent upon CREB gene expression . It is likely that both formation of new synapses and consolidation of old ones are involved in the delayed and long-term effects of Uch-L1 treatment. The discrepancy between rolipram and Uch-L1 effects may be linked to the differences in their mechanisms of action. Treatment with Uch-L1 fusion protein does not rescue the decrease in cAMP levels caused by Ab ( Figure S9B ), whereas rolipram is known to increase cAMP levels and then PKA activity (Barad et al., 1998) . Based on these findings it is tempting to hypothesize that retrieval of spatial memories are more clearly linked to the elevation of cAMP levels, whereas proteasomal activity plays a greater role in contextual memories.
Uch-L1 is widely distributed in central neurons. However, our studies show that Uch-L1 inhibition does not affect cued conditioning, whereas it impairs contextual learning. The amygdala is involved mainly in cued conditioning, while the hippocampus is required for contextual learning (Phillips and LeDoux, 1992) . Thus, these data suggest that Uch-L1 is critical to learning and memory processes in the hippocampus but not amygdala, but they do not rule out the possibility that memory processes in amygdala are sensitive to Uch-L1 in a timeframe other than the one tested here. Similarly, we have found that inhibition of Uch-L1 activity during a narrow time window at 4 hr after training (but not at 4 and 1 hr before training or at 1 hr after training; see Supplemental Experimental Procedures) affected contextual learning. It is also possible that other pathways compensate for the Uch-L1 inhibition in amygdala but not in hippocampus. For instance, there is a specific and critical activation of phosphatidylinositol 3-kinase in the amygdala after LTP induction and after fear conditioning (Lin et al., 2001) . Together, these findings strengthen the idea of multiple memory systems and suggest that inhibition of Uch-L1 can differentially affect them.
A significant difference between the effects of Ab and Uch-L1 on LTP is that response to Ab (20 min or less) is more rapid than response to LDN (2 hr). Examination of hippocampal slices from wt mice after 20 min of treatment with oligomeric Ab shows a decrease of 30% in Uch activity, a fall of 70% in monoubiquitin levels, a fall of 30% in PKA activity, and an increase in PKA-R subunit levels. These data are consistent with the model we have previously proposed where a fall in cAMP shifts the equilibrium of the PKA complex toward the inactive form, resulting in decreased CREB phosphorylation and transcription (Vitolo et al., 2002) . The current data show that there is an equally rapid decrease in Uch-L1 and proteasome activity as reflected in monoubiquitin levels. The fact that, in cell culture, the glutamate-induced increase in CREB phosphorylation and PKA activity are restored by V-Uch-L1 in the presence of Ab without any alteration in cAMP levels suggests that Uch-L1 is downstream of cAMP in this pathway (Supplemental Results) . Treatment with LDN also results in a rapid fall of Uch-L1 activity, but proteasome inhibition has no effect on cAMP levels over a period of several hours (Z. Cao, personal communication). Therefore, it seems that Uch-L1 does not directly affect the dissociation of the PKA complex and that inhibition of LTP does not occur until there has been accumulation of the PKA-R subunit (PKA-R) to levels sufficient to depress PKA activity and CREB phosphorylation. A similar pattern is seen with DUNC-13, the Drosophila homolog of the PKA-regulated, CREB-like synaptic protein UNC-13, that takes 60-90 min to accumulate following block of the proteasome with lactacystin (Aravamudan and Broadie, 2003) . The rapid fall in Uch-L1 activity in response to Ab raises the possibility that Ab initiates a signaling cascade, perhaps mediated by cAMP, that results in the partial inhibition of proteasome activity more rapidly than is likely as the result of the accumulation of misfolded or undigestable proteins.
Our data suggest that Uch-L1 could be an attractive target for the development of new therapeutic approaches to AD, either alone or in combination with therapies that alter Ab levels.
EXPERIMENTAL PROCEDURES
Animals
Animal studies followed protocols approved by the Animal Use and Care Committee of Columbia University. We utilized either C57/BL6 mice (Jackson Lab) or APP/PS1 mice. Tg mice expressing both human APP (K670N:M671L) and human PS1 (M146L) (line 6.2) were compared to their wt littermates, obtained by crossing heterozygous APP with PS1 animals, so that age and background strain were comparable. Genotype was identified by PCR (Gong et al., 2004) .
Slice Preparation
Mice were decapitated and their hippocampi removed. Transverse hippocampal slices (400 mm) were maintained in an interface chamber at 29 C as previously described (Vitolo et al., 2002 ) (see Supplemental Experimental Procedures).
Hydrolase Activity
The hydrolase assay was performed as previously described (Nishikawa et al., 2003) with slight modifications. Hippocampal tissue was treated with tissue protein extraction reagent (Pierce) with freshly added EDTA-free protease inhibitors. The homogenate was centrifuged at 10,000 rpm for 5 min. Protein concentration was measured in the supernatant using the BCA protein assay reagent. In some experiments hydrolysis was initiated by adding 10 ml of 20 nM Uch-L1 or Uch-L3 (Boston Biochem). The hydrolase assay was performed using fluorogenic ubiquitin-7-amino-4-methylcoumarin (ubiquitin-AMC) (Boston Biochem) as a substrate. The substrate was diluted in assay buffer (50 mM Tris-HCL, 0.5 mM EDTA, 5 mM dithiothreitol, and 0.1 mg/ml ovalbumin, pH 7.6). Reaction mixtures containing 400 nM substrate and 100 mg enzyme sample was incubated for 5 min at room temperature. The reaction was monitored using a fluorescence spectrophotometer (CytoFluor Series 4000, ABI Inc) at 25 C. The free AMC fluorophore was excited at 380 nm and measured at 460 nm.
Hydrolase activity was expressed as relative fluorescence intensity/ min (Dang et al., 1998) . In some experiments, hydrolysis was also measured on the soluble and insoluble fractions ( Figure 4D ). In a group of experiments, hydrolysis was measured by mixing ubiquitin-AMC with 20 nM TAT fusion proteins ( Figure 3C ). In other experiments the substrate was Nedd8-AMC (Boston Biochem). LDN-57444 was purchased from Calbiochem.
Electrophysiological Recordings
The fEPSPs were recorded from the CA1 region of the hippocampus by placement of both the stimulating and the recording electrodes in the CA1 stratum radiatum, as previously described (Vitolo et al., 2002 ) (see Supplemental Experimental Procedures). Briefly, BST was assayed by plotting the stimulus voltage (V) against slopes of fEPSP to generate input-output relations or by plotting the peak amplitude of the fiber volley against the slope of the fEPSP to generate input-output relations. LTP was induced using theta-burst stimulation (4 pulses at 100 Hz, with the bursts repeated at 5 Hz, and each tetanus including three 10 burst trains separated by 15 s). Each point of the graphs represents the average of three successive events.
Western Blotting
Protein levels were assessed using standard procedures (see Supplemental Experimental Procedures). The following antibodies were used: mouse monoclonal anti-ubiquitin (Chemicon), rabbit polyclonal antipCREB (Upstate Biotech.), rabbit polyclonal anti-PKA-RIIa (Santa Cruz Biotech. Inc), mouse monoclonal anti-Uch-L1 (Novocastra), and monoclonal mouse anti-HA (Santa Cruz Biotech. Inc). Detection was performed using HRP-conjugated secondary antibodies (Pierce, Rockford, IL).
Expression and Purification of Recombinant TAT Fusion Proteins
Following construct preparation (see Supplemental Experimental Procedures), TAT vectors were transformed into E. Coli BL21(DE3)pLysScompetent cells (Novagen), and independent colonies were grown as 1 ml overnight cultures in Luria broth (LB) medium (Sigma), with 100 mg ampicillin, in the presence of 100 mM IPTG. Then the cultures were transferred to 500 ml LB ampicillin plus 200 mM IPTG to make large-scale preparations. Fusion proteins were purified by a standard 6-His fusion protein purification protocol using ProBond purification system (Invitrogen). Protein identity was confirmed by Western blotting using mouse anti-human monoclonal antibody against Uch-L1 (Novocastra Lab) and mouse monoclonal anti-HA (Santa Cruz Biotech).
Visualization of TAT Fusion Proteins
Immunocytochemistry of hippocampal slices was performed as previously described (Puzzo et al., 2005) with slight modifications (see Supplemental Experimental Procedures). Briefly, 400 mm slices were fixed in 4% paraformaldehyde/PBS after perfusion with the fusion protein or vehicle for 1 hr. After washing with PBS, slices were treated with 0.2% Triton X-100 and incubated in 5% goat serum for 30 min. Slices were then incubated with primary antibodies (either anti-Uch-L1 or anti-HA) overnight at 4 C. Finally, slices were incubated with secondary antibodies (goat anti-mouse IgG FITC and TRITC, respectively) and examined with a confocal microscope. Kalman averages of four scans were collected for each image that was analyzed with Image J 1.33u NIH image software. The mean fluorescence intensity that exceeded a threshold set above background was determined for each slice in CA1 cell body area. The values were normalized to the values from vehicletreated control slices from the same animal and expressed as mean percent of control ± SEM. For all the immunocytochemistry, the specificity of the immunofluorescence was confirmed by omitting the primary antibody, which resulted in a significant reduction in fluorescence intensity.
Quantitative RT-PCR Analysis Total RNAs were extracted using standard procedures for reverse transcription with SuperScript (Invitrogen) and PCR with GeneAmp2400 (Applied Biosystems) (see Supplemental Experimental Procedures).
Behavioral Studies
Fear conditioning was performed as previously described (Bourtchuladze et al., 1994) . For contextual and cued conditioning, mice were placed in a conditioning chamber for 2 min before the onset of a tone (CS) (a 30 s, 85 dB sound at 2800 Hz). In the last 2 s of the CS, mice were given a 2 s, 0.50 mA foot shock (US) through the bars of the floor. After the CS/US pairing, the mice were left in the conditioning chamber for another 30 s and were then placed back in their home cages. Freezing behavior, defined as the absence of all movement except for that necessitated by breathing, was scored using the Freezeview software.
To evaluate contextual fear learning, freezing was measured 24 hr after training for 5 min (consecutive) in the chamber in which the mice were trained. To evaluate cued fear learning, 24 hr after contextual testing, mice were placed in a novel context for 2 min (pre-CS test), after which they were exposed to the CS for 3 min (CS test), and freezing was measured. To evaluate the contextual fear over time, 7, 14, and 21 days after training, mice were placed for 5 min in the chamber in which the mice were trained. Sensory perception of the shock was determined through threshold assessment, as described (Gong et al., 2004 ) (see Supplemental Experimental Procedures).
Quantification of Amyloid Peptides by ELISA Levels of human brain Ab were determined on protein-containing supernatants by sandwich Ab1-42 ELISA kit (Sigma BE0200) using standard procedures. Signals were detected with a multiwell plate reader at 450 nm and reported as the mean ± SEM of the results of two replica wells in picomoles of Ab per milligram of protein (protein concentration was determined with the BCA Protein Assay Kit).
PKA Kinase Activity Measurement
Hippocampal slices were lysed with RIPA lysis buffer and homogenized by Dounce homogenizer on ice. Five DIV primary cultures were treated for 24 hr and cells were lysed with RIPA lysis buffer. Levels of intracellular PKA kinase activity were measured by PKA Kinase Activity Assay Kit (Stressxpress) according to manufacturer's instructions.
Phospho-CREB Measurements
Hippocampal slices were fixed in ice-cold 4% paraformaldehyde at 60 min after the treatment (Puzzo et al., 2005) then washed three times in phosphate-buffered saline (PBS), treated with 0.3% Triton X-100 for 60 min, washed three times in PBS again, treated with 50 mM ammonium chloride for 20 min, and incubated in 10% goat serum for 60 min. Slices were next incubated with the primary antibody (rabbit polyclonal antiphospo-CREB from Upstate Biotechnology diluted 1:100 in 10% goat serum) for 36 hr at 4 C. Then, slices were washed in PBS (six times, 2 hr each time), incubated with the secondary antibody (goat antirabbit antibody labeled with Alexa Fluor 488, from Molecular Probes), diluted 1:100 in 10% goat serum for 12 hr at 4 C, and washed in PBS again (six times, 2 hr each time). Finally, slices were examined with a confocal microscope and analyzed as described above for ''Visualization of TAT-fusion Proteins.''
Statistics
For all experiments mice were coded by ''blind'' investigators with respect to genotype and treatment. Data were expressed as mean ± SEM. Data were analyzed by Student's t test (pairwise comparisons) or ANOVA with repeated measures (multiple comparisons) followed by Bonferroni's test for post-hoc analysis. 
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